Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Watson Pharma Inc.

Division of Allergan PLC

Latest From Watson Pharma Inc.

Stada Takeover Saga Set To Run As US Fund Seeks More Cash

As Elliott Management pushes for a premium to back the takeover of the German drug maker by Bain and Cinven, the private equity firms have unveiled industry veteran Claudio Albrecht as Stada's latest CEO.

M & A Legal Issues

Teva CEO Steps Down While An Integration Hangs In The Balance

After a damaging court ruling on Copaxone 40 mg and some management missteps, CEO Erez Vigodman will step down as CEO of the Israeli generic drug leader. Chairman Yitzhak Peterburg will fill in on an interim basis.

Generic Drugs Leadership

VC Roundup: Flagship’s New Fund Designed To Raise Its Stake In Startups

Newly renamed Flagship Pioneering has raised a $285m venture capital fund to remain invested in portfolio companies as they grow. Also, 12 new and growing biopharma companies raised $657.15m.

Commercial StartUps and SMEs

Biosimilars: The Unlikely Hero Of Specialty Pharma?

In the patent cliff musical chairs game, the music has stopped and generic companies like Mylan and Teva are looking for the next growth driver. While this seems to be biosimilars, it appears that innovator companies who are used to developing biologics, are already sitting in their seats.

Commercial Biosimilars
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Generic Drugs
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Schein Pharmaceutical Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Allergan PLC
  • Senior Management
  • Whitney Stearns, CFO
    Dariush Ashrafi, Pres. & COO
    Ken Albert, PhD, VP, R&D
  • Contact Info
  • Watson Pharma Inc.
    Phone: (201) 593-5500
    100 Campus Dr.
    Florham Park, NJ 07932
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register